Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia
- PMID: 12697918
- PMCID: PMC1742624
- DOI: 10.1136/pmj.79.929.164
Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia
Abstract
Pneumocystis carinii pneumonia (PCP) remains a serious opportunistic infection in HIV infected individuals. Seasonal changes in climate are associated with changes within individual susceptibility to infection. The possibility of monthly variability in the incidence of PCP was therefore examined by means of a cohort study of a database of 8640 HIV infected individuals attending the Chelsea and Westminster Hospital. There were 792 cases of PCP diagnosed since 1985. A marked decline was observed in the incidence of PCP in mid-1992 coincident with the introduction of PCP prophylaxis. There was a further decline in 1996 after the introduction of highly active antiretroviral therapy. Despite no significant monthly variation in the mean attendance to clinic and CD4 count, both new and all cases of PCP were higher in January than in other months (15.9% and 14.5% of all cases, respectively). A correlation with low rainfall in January and new cases of PCP was observed. These data are consistent with an influence of climatic conditions on the presentation of PCP. The diagnosis of PCP is more common in winter months suggesting that this is a transmissible infection.
Similar articles
-
Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.N Engl J Med. 1995 Mar 23;332(12):786-90. doi: 10.1056/NEJM199503233321206. N Engl J Med. 1995. PMID: 7862183
-
Pneumocystis pneumonia--a retrospective study 1991-2001 in Gothenburg, Sweden.J Infect. 2006 Oct;53(4):260-5. doi: 10.1016/j.jinf.2005.06.014. Epub 2006 Jan 3. J Infect. 2006. PMID: 16403575
-
Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):151-8. doi: 10.1097/00042560-200102010-00007. J Acquir Immune Defic Syndr. 2001. PMID: 11242182
-
Current epidemiology of Pneumocystis pneumonia.Emerg Infect Dis. 2004 Oct;10(10):1713-20. doi: 10.3201/eid1010.030985. Emerg Infect Dis. 2004. PMID: 15504255 Free PMC article. Review.
-
Pneumocystis carinii pneumonia.Semin Respir Infect. 1999 Dec;14(4):333-43. Semin Respir Infect. 1999. PMID: 10638513 Review.
Cited by
-
Environmental risk factors for Pneumocystis pneumonia hospitalizations in HIV patients.Clin Infect Dis. 2013 Jan;56(1):74-81. doi: 10.1093/cid/cis841. Epub 2012 Oct 5. Clin Infect Dis. 2013. PMID: 23042978 Free PMC article.
-
The Relationship between Pneumocystis Infection in Animal and Human Hosts, and Climatological and Environmental Air Pollution Factors: A Systematic Review.OBM Genet. 2018;2(4):10.21926/obm.genet.1804045. doi: 10.21926/obm.genet.1804045. Epub 2018 Oct 26. OBM Genet. 2018. PMID: 30815637 Free PMC article.
-
Pneumocystis Pneumonia in Solid-Organ Transplant Recipients.J Fungi (Basel). 2015 Sep 28;1(3):293-331. doi: 10.3390/jof1030293. J Fungi (Basel). 2015. PMID: 29376913 Free PMC article. Review.
-
Transmission and Colonization of Pneumocystis jirovecii.J Fungi (Basel). 2021 Nov 18;7(11):979. doi: 10.3390/jof7110979. J Fungi (Basel). 2021. PMID: 34829266 Free PMC article. Review.
-
The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities.J Eukaryot Microbiol. 2013 Nov-Dec;60(6):634-45. doi: 10.1111/jeu.12072. Epub 2013 Sep 3. J Eukaryot Microbiol. 2013. PMID: 24001365 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials